Parkinson's Foundation Taps Tag.bio for PD GENEration Data Sharing, Analysis
The foundation will use Tag.bio's software to link anonymized clinical and genomic datasets to research Parkinson's disease causes and personalized treatment.
Twenty-three out of 50 planned study sites are now active, and a partnership with Morehouse School of Medicine will help with minority recruitment.
Sanofi Commits $1M to Support Parkinson's Disease Genetic Testing Study
The drugmaker has a small molecule drug called venglustat under Phase II development for Parkinson's disease patients with a specific genetic mutation.
Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling
The sites include Massachusetts General Hospital, Northwestern Medicine, Struthers Parkinson's Center, UC San Diego, and the Perelman School of Medicine.